Cycloserine-Induced Psychosis: A Case Report

Overview

Journal Cureus

Date 2025 Feb 7

PMID 39917143

Authors

Shrinivas R Raikar

Sreeraj G

Sneha Sneha

Janarthanan Rajkumar

Affiliations

Soon will be listed here.

Abstract

Tuberculosis (TB) is a highly infectious disease and a global health challenge caused by . The disease presents as drug-sensitive TB or drug-resistant TB (DR-TB). DR-TB could be of various types like isoniazid mono-resistant, multidrug-resistant (MDR)-rifampicin mono-resistant (MDR-RR), MDR-TB, extensively DR-TB (XDR-TB), or pre-XDR-TB. Management of DR-TB is challenging due to the longer treatment duration and adverse drug reactions (ADRs) to the second-line anti-TB drugs. Some of these could be life-threatening and require urgent care. Neuropsychiatric ADRs associated with cycloserine require greater attention due to their potential to cause treatment failure. The objective of this case report is to emphasize the importance of awareness about psychiatric ADRs caused by antitubercular agents. It also highlights the reversible nature of these adverse events upon drug withdrawal. To ensure methodological rigor in the assessment of psychosis, the Brief Psychiatric Rating Scale (BPRS) and Naranjo ADR Probability Scale were employed as diagnostic tools to evaluate the severity of psychiatric symptoms and establish the likelihood of an ADR, respectively. It is emphasized here that proper vigilance with immediate management is essential to avoid fatal outcomes. Herein, a case of ADR caused by cycloserine in a pulmonary MDR-TB case as a part of a new modified longer regimen in the Department of Respiratory Medicine at Shri B M Patil Medical College, Hospital and Research Centre, Vijayapura, Karnataka, is presented.

References

Yadav S . Cycloserine-Induced Insomnia and Psychosis in Multidrug-Resistant Pulmonary Tuberculosis - A Case Report. Cureus. 2023; 14(12):e32963. PMC: 9875866. DOI: 10.7759/cureus.32963. View

Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30(2):239-45. DOI: 10.1038/clpt.1981.154. View

Sharma B, Handa R, Nagpal K, Prakash S, Gupta P, Agrawal R . Cycloserine-induced psychosis in a young female with drug-resistant tuberculosis. Gen Hosp Psychiatry. 2014; 36(4):451.e3-4. DOI: 10.1016/j.genhosppsych.2014.03.009. View

Emmett M, Mick S, Cler J, Rao T, Iyengar S, Wood P . Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo. Neuropharmacology. 1991; 30(11):1167-71. DOI: 10.1016/0028-3908(91)90161-4. View

van Berckel B, Lipsch C, Gispen-de Wied C, Wynne H, Blankenstein M, van Ree J . The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers. Psychopharmacology (Berl). 1998; 138(2):190-7. DOI: 10.1007/s002130050662. View

Oh P, Pascopella L, Barry P, Flood J . A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015. BMC Res Notes. 2017; 10(1):434. PMC: 5577675. DOI: 10.1186/s13104-017-2754-y. View

Li Y, Wang F, Wu L, Zhu M, He G, Chen X . Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China. Infect Drug Resist. 2019; 12:721-731. PMC: 6445236. DOI: 10.2147/IDR.S195555. View

Deshpande D, Alffenaar J, Koser C, Dheda K, Chapagain M, Simbar N . d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal. Clin Infect Dis. 2018; 67(suppl_3):S308-S316. PMC: 6260153. DOI: 10.1093/cid/ciy624. View

Lee-Rodriguez C, Wada P, Hung Y, Skarbinski J . Association of Mortality and Years of Potential Life Lost With Active Tuberculosis in the United States. JAMA Netw Open. 2020; 3(9):e2014481. PMC: 7512053. DOI: 10.1001/jamanetworkopen.2020.14481. View

10.

Tandon V, Rani N, Roshi , Gupta R, Arora M, Khajuria V . Cycloserine induced psychosis with hepatic dysfunction. Indian J Pharmacol. 2015; 47(2):230-1. PMC: 4386140. DOI: 10.4103/0253-7613.153439. View

11.

Intini E, Kishore G, Richeldi L, Udwadia Z . Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us. BMJ Case Rep. 2019; 12(12). PMC: 6904180. DOI: 10.1136/bcr-2019-230993. View

12.

Tornheim J, Udwadia Z, Arora P, Gajjar I, Gupte N, Sharma S . Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis. Eur Respir J. 2021; 59(3). PMC: 8943271. DOI: 10.1183/13993003.02511-2021. View